Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
71,085,776
-
Total 13F shares
-
43,853,431
-
Share change
-
-559,691
-
Total reported value
-
$136,378,109
-
Put/Call ratio
-
29%
-
Price per share
-
$3.11
-
Number of holders
-
109
-
Value change
-
-$468,454
-
Number of buys
-
50
-
Number of sells
-
60
Institutional Holders of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) as of Q3 2025
As of 30 Sep 2025,
Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,853,431 shares.
The largest 10 holders included
Affinity Asset Advisors, LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., TANG CAPITAL MANAGEMENT LLC, MARSHALL WACE, LLP, Vestal Point Capital, LP, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, Ikarian Capital, LLC, and BlackRock, Inc..
This page lists
109
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.